News

A phase II study of thalidomide and temozolomide in patients with brain metastases from malignant melanoma: lymphopenia correlates with response - resized_Pizzigoni4crop.jpg

Study in US veterans identifies agent orange exposure as a risk factor for rare skin cancer

5 February 2026
antigen-capturing nanoparticles - immunotherapy

Yeast cells can be used for rapid testing of cancer immunotherapy

5 February 2026
Doctor generic

Scientists crack the rules of gene regulation with experimental elegance and AI

5 February 2026
generic researcher lab microscope

Scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumours

5 February 2026
Cancer cells in culture from human connective tissue - NCI Visuals

Unlocking “hidden” modes: A new physics-driven approach to label-free cancer cell phenotyping

5 February 2026
Artificial Intelligence

AI tool predicts brain age, cancer survival, and other disease signals from unlabeled brain MRIs

5 February 2026
blood test

Testing menstrual blood for HPV could be “robust alternative” to cervical screening

5 February 2026
molecules

Five mutational “fingerprints” could help predict how visible tumours are to the immune system

5 February 2026
paediatric child

Personalised palliative care shows signs of improving quality of life for children with advanced cancer

5 February 2026
breast surgery training Venezuela

Updated guidelines standardise how tumour response is measured after surgery

5 February 2026
Cancer immunotherapy enables T cells (front) to attack and eliminate tumour cells (dark red)

A double-edged sword: Chronic cellular stress promotes liver cancer—but also makes tumours vulnerable to immunotherapy

5 February 2026
FOOD

High consumption of ultraprocessed foods may be linked to cancer survivors’ risk of death

4 February 2026
Back to Top